Trial Profile
Pharmacokinetics and Pharmacodynamics of subcutaneous applied insulin aspart administered with the FlexPen insulin pen compared to inhaled insulin administered with the Exubera device.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Nov 2012
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin; Insulin detemir
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 25 Jul 2011 New trial record